Abacavir
The serum concentration of Abacavir can be decreased when it is combined with Fosinopril.
Acebutolol
Fosinopril may increase the hypotensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Fosinopril.
Advertisement
Acemetacin
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Acemetacin.
Acetyl salicylate
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Acetylsalicylic acid.
Adapalene
The risk or severity of adverse effects can be increased when Adapalene is combined with Fosinopril.
Advertisement
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fosinopril.
Alfuzosin
The serum concentration of Alfuzosin can be increased when it is combined with Fosinopril.
Aliskiren
Aliskiren may increase the hypotensive, nephrotoxic, and hyperkalemic activities of Fosinopril.
Advertisement
Allopurinol
The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Fosinopril.
Alminoprofen
The risk or severity of adverse effects can be increased when Alminoprofen is combined with Fosinopril.
Alogliptin
The risk or severity of adverse effects can be increased when Alogliptin is combined with Fosinopril.
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aloxiprin
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Aloxiprin.
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Fosinopril.
Alprenolol
Fosinopril may increase the hypotensive activities of Alprenolol.
Aluminum
Aluminium can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ambrisentan
Fosinopril may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Fosinopril.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Fosinopril.
Amifostine
Fosinopril may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Fosinopril may increase the hypotensive activities of Amifostine.
Amiloride
Amiloride may increase the hyperkalemic activities of Fosinopril.
Amineptin
The serum concentration of Amineptine can be increased when it is combined with Fosinopril.
Aminophylline
The serum concentration of Aminophylline can be decreased when it is combined with Fosinopril.
Aminosalicylic Acid
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Aminosalicylic Acid.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Fosinopril.
Amitriptyline
The serum concentration of Amitriptyline can be increased when it is combined with Fosinopril.
Amlodipine
Amlodipine may increase the hypotensive activities of Fosinopril.
Amobarbital
Amobarbital may increase the hypotensive activities of Fosinopril.
Amoxapine
The serum concentration of Amoxapine can be increased when it is combined with Fosinopril.
Amphetamine
Amphetamine may increase the hypotensive activities of Fosinopril.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Fosinopril.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Fosinopril.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Fosinopril is combined with Amyl Nitrite.
Anhydrous Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Fosinopril.
Antipyrine
The risk or severity of adverse effects can be increased when Antipyrine is combined with Fosinopril.
Apazone
The risk or severity of adverse effects can be increased when Azapropazone is combined with Fosinopril.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Fosinopril.
Apraclonidine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Apraclonidine.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Fosinopril.
Aprotinin
Aprotinin may decrease the antihypertensive activities of Fosinopril.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Fosinopril.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fosinopril.
Aspirin
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Acetylsalicylic acid.
Atenolol
Atenolol may increase the hypotensive activities of Fosinopril.
Atorvastatin
The risk or severity of adverse effects can be increased when Atorvastatin is combined with Fosinopril.
Avanafil
Avanafil may increase the antihypertensive activities of Fosinopril.
Azathioprine
The risk or severity of anemia and severe leukopenia can be increased when Fosinopril is combined with Azathioprine.
Azelastine
The risk or severity of adverse effects can be increased when Azelastine is combined with Fosinopril.
Azilsartan
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Fosinopril.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Fosinopril.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Fosinopril.
Azosemide
Azosemide may increase the hypotensive activities of Fosinopril.
Balsalazide
The risk or severity of adverse effects can be increased when Balsalazide is combined with Fosinopril.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Fosinopril.
Barbital
Barbital may increase the hypotensive activities of Fosinopril.
Benazepril
Fosinopril may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
The risk or severity of hypotension can be increased when Bendroflumethiazide is combined with Fosinopril.
Benzthiazide
The risk or severity of hypotension can be increased when Benzthiazide is combined with Fosinopril.
Benzydamine
The risk or severity of adverse effects can be increased when Benzydamine is combined with Fosinopril.
Bepridil
Fosinopril may increase the hypotensive activities of Bepridil.
Betaxolol
Betaxolol may increase the hypotensive activities of Fosinopril.
Bethanidine
Bethanidine may increase the hypotensive activities of Fosinopril.
Bimatoprost
Fosinopril may increase the hypotensive activities of Bimatoprost.
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth Subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bisoprolol
Fosinopril may increase the hypotensive activities of Bisoprolol.
Boceprevir
The serum concentration of Fosinopril can be decreased when it is combined with Boceprevir.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Fosinopril.
Bosentan
Bosentan may increase the hypotensive activities of Fosinopril.
Bosentan Anhydrous
Bosentan may increase the hypotensive activities of Fosinopril.
Bretylium
Fosinopril may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Fosinopril.
Bromfenac
The risk or severity of adverse effects can be increased when Bromfenac is combined with Fosinopril.
Bromocriptine
The serum concentration of Bromocriptine can be increased when it is combined with Fosinopril.
Bufexamac
The risk or severity of adverse effects can be increased when Bufexamac is combined with Fosinopril.
Bumetanide
Bumetanide may increase the hypotensive activities of Fosinopril.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Fosinopril.
Bupranolol
Fosinopril may increase the hypotensive activities of Bupranolol.
Butriptyline
The serum concentration of Butriptyline can be increased when it is combined with Fosinopril.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Fosinopril.
Cafedrine
Fosinopril may increase the hypotensive activities of Cafedrine.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Canagliflozin
The risk or severity of renal failure and hyperkalemia can be increased when Canagliflozin is combined with Fosinopril.
Canagliflozin Anhydrous
The risk or severity of renal failure and hyperkalemia can be increased when Canagliflozin is combined with Fosinopril.
Candesartan
The risk or severity of adverse effects can be increased when Candesartan is combined with Fosinopril.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Fosinopril.
Captopril
Fosinopril may increase the hypotensive activities of Captopril.
Carbamazepine
The metabolism of Fosinopril can be increased when combined with Carbamazepine.
Carprofen
The risk or severity of adverse effects can be increased when Carprofen is combined with Fosinopril.
Carteolol
Fosinopril may increase the hypotensive activities of Carteolol.
Carvedilol
Fosinopril may increase the hypotensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Celecoxib is combined with Fosinopril.
Celiprolol
Fosinopril may increase the hypotensive activities of Celiprolol.
Chloroquine
The risk or severity of adverse effects can be increased when Chloroquine is combined with Fosinopril.
Chlorothiazide
The risk or severity of hypotension can be increased when Chlorothiazide is combined with Fosinopril.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Fosinopril.
Chlorthalidone
The risk or severity of hypotension can be increased when Chlorthalidone is combined with Fosinopril.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fosinopril.
Cicletanine
Fosinopril may increase the hypotensive activities of Cicletanine.
Cilazapril
Fosinopril may increase the hypotensive activities of Cilazapril.
Ciprofloxacin
The risk or severity of ventricular arrhythmias can be increased when Fosinopril is combined with Ciprofloxacin.
Clarithromycin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Fosinopril.
Clevidipine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Fosinopril is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Fosinopril.
Clomipramine
The serum concentration of Clomipramine can be increased when it is combined with Fosinopril.
Clonidine
Clonidine may increase the hypotensive activities of Fosinopril.
Clonixin
The risk or severity of adverse effects can be increased when Clonixin is combined with Fosinopril.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Fosinopril.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Fosinopril.
Cryptenamine
Fosinopril may increase the hypotensive activities of Cryptenamine.
Curcumin
The risk or severity of adverse effects can be increased when Curcumin is combined with Fosinopril.
Cyclopenthiazide
The risk or severity of hypotension can be increased when Cyclopenthiazide is combined with Fosinopril.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Fosinopril is combined with Cyclophosphamide.
Cyclophosphamide Anhydrous
The risk or severity of adverse effects can be increased when Fosinopril is combined with Cyclophosphamide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Fosinopril.
Cyclothiazide
Fosinopril may increase the hypotensive activities of Cyclothiazide.
Dapagliflozin
The risk or severity of adverse effects can be increased when Fosinopril is combined with Dapagliflozin.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Fosinopril.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Fosinopril.
Deserpidine
Fosinopril may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Fosinopril.
Desipramine
The serum concentration of Desipramine can be increased when it is combined with Fosinopril.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Dexmedetomidine.
Diazoxide
Diazoxide may increase the hypotensive activities of Fosinopril.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Fosinopril is combined with Diclofenamide.
Diclofenac
The risk or severity of adverse effects can be increased when Diclofenac is combined with Fosinopril.
Diethylstilbestrol
The serum concentration of Diethylstilbestrol can be decreased when it is combined with Fosinopril.
Diflunisal
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Diflunisal.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Fosinopril.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Fosinopril.
Dihydroergotamine
The serum concentration of Dihydroergotamine can be increased when it is combined with Fosinopril.
Diltiazem
The metabolism of Diltiazem can be decreased when combined with Fosinopril.
Dinutuximab
The risk or severity of adverse effects can be increased when Fosinopril is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Fosinopril is combined with Dipyridamole.
Dipyrone
The risk or severity of adverse effects can be increased when Metamizole is combined with Fosinopril.
Dorzolamide
Fosinopril may increase the hypotensive activities of Dorzolamide.
Dothiepin
The serum concentration of Dosulepin can be increased when it is combined with Fosinopril.
Doxazosin
Doxazosin may increase the hypotensive activities of Fosinopril.
Doxepin
The serum concentration of Doxepin can be increased when it is combined with Fosinopril.
Drospirenone
Fosinopril may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Droxicam is combined with Fosinopril.
Duloxetine
Fosinopril may increase the orthostatic hypotensive activities of Duloxetine.
Dyphylline
The serum concentration of Dyphylline can be decreased when it is combined with Fosinopril.
Empagliflozin
The risk or severity of adverse effects can be increased when Fosinopril is combined with Empagliflozin.
Enalapril
Fosinopril may increase the hypotensive activities of Enalapril.
Enalaprilat
Fosinopril may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Fosinopril may increase the hypotensive activities of Enalaprilat.
Enfuvirtide
The serum concentration of Enfuvirtide can be increased when it is combined with Fosinopril.
Eplerenone
Eplerenone may increase the hyperkalemic activities of Fosinopril.
Epoprostenol
Fosinopril may increase the hypotensive activities of Epoprostenol.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Fosinopril.
ergoloid mesylates, USP
The serum concentration of Ergoloid mesylate can be increased when it is combined with Fosinopril.
Ergonovine
The serum concentration of Ergonovine can be increased when it is combined with Fosinopril.
Ergotamine
The serum concentration of Ergotamine can be increased when it is combined with Fosinopril.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Fosinopril.
Estradiol
The serum concentration of Estradiol can be decreased when it is combined with Fosinopril.
Estradiol Cypionate
The serum concentration of Estradiol cypionate can be decreased when it is combined with Fosinopril.
Estradiol Valerate
The serum concentration of Estradiol valerate can be decreased when it is combined with Fosinopril.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Fosinopril.
Ethacrynate
Etacrynic acid may increase the hypotensive activities of Fosinopril.
Ethacrynic Acid
Etacrynic acid may increase the hypotensive activities of Fosinopril.
Ethinyl Estradiol
The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Fosinopril.
Etodolac
The risk or severity of adverse effects can be increased when Etodolac is combined with Fosinopril.
Etofenamate
The risk or severity of adverse effects can be increased when Etofenamate is combined with Fosinopril.
Etoricoxib
The risk or severity of adverse effects can be increased when Etoricoxib is combined with Fosinopril.
Etravirine
The serum concentration of Etravirine can be decreased when it is combined with Fosinopril.
Evening primrose oil
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Fosinopril.
Everolimus
The risk or severity of adverse effects can be increased when Everolimus is combined with Fosinopril.
Felbinac
The risk or severity of adverse effects can be increased when Felbinac is combined with Fosinopril.
Felodipine
Fosinopril may increase the hypotensive activities of Felodipine.
Fenbufen
The risk or severity of adverse effects can be increased when Fenbufen is combined with Fosinopril.
Fenoldopam
Fosinopril may increase the hypotensive activities of Fenoldopam.
Fenoprofen
The risk or severity of adverse effects can be increased when Fenoprofen is combined with Fosinopril.
Ferulic Acid
Fosinopril may increase the hypotensive activities of Ferulic acid.
Fibrinolysis Inhibitor
Aprotinin may decrease the antihypertensive activities of Fosinopril.
Floctafenine
The risk or severity of adverse effects can be increased when Floctafenine is combined with Fosinopril.
Flurbiprofen
The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Fosinopril.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Fosinopril.
Furazolidone
Furazolidone may increase the hypotensive activities of Fosinopril.
Furosemide
Furosemide may increase the hypotensive activities of Fosinopril.
Garlic Allergenic Extract
The serum concentration of Fosinopril can be decreased when it is combined with Garlic.
Gold Sodium Thiomalate
The risk or severity of hypotension, nitritoid reactions, facial flushing, nausea, and vomiting can be increased when Fosinopril is combined with Sodium aurothiomalate.
Guanabenz
Fosinopril may increase the hypotensive activities of Guanabenz.
Guanadrel
Guanadrel may increase the hypotensive activities of Fosinopril.
Guanethidine
Fosinopril may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Fosinopril.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Fosinopril.
Heparin
The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Heparin.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Fosinopril.
Hydralazine
Hydralazine may increase the hypotensive activities of Fosinopril.
Hydrochlorothiazide
The risk or severity of hypotension can be increased when Hydrochlorothiazide is combined with Fosinopril.
Hydroflumethiazide
The risk or severity of hypotension can be increased when Hydroflumethiazide is combined with Fosinopril.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Hypoxis hemerocallidea root extract
The metabolism of Fosinopril can be increased when combined with St. John's Wort.
Ibuprofen
The risk or severity of adverse effects can be increased when Ibuprofen is combined with Fosinopril.
Icatibant
Icatibant may decrease the antihypertensive activities of Fosinopril.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Fosinopril.
Imidapril
Fosinopril may increase the hypotensive activities of Imidapril.
Imipramine
The serum concentration of Imipramine can be increased when it is combined with Fosinopril.
Indapamide
The risk or severity of hypotension can be increased when Indapamide is combined with Fosinopril.
Indobufen
The risk or severity of adverse effects can be increased when Indobufen is combined with Fosinopril.
Indomethacin
The risk or severity of adverse effects can be increased when Indomethacin is combined with Fosinopril.
Indoramin
Indoramin may increase the hypotensive activities of Fosinopril.
Iproniazid
Iproniazid may increase the hypotensive activities of Fosinopril.
Irbesartan
The risk or severity of adverse effects can be increased when Irbesartan is combined with Fosinopril.
Iron
Iron can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Iron can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
The risk or severity of adverse effects can be increased when Fosinopril is combined with Iron Dextran.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Fosinopril.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Fosinopril.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Fosinopril is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Fosinopril is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Fosinopril.
Kebuzone
The risk or severity of adverse effects can be increased when Kebuzone is combined with Fosinopril.
Ketanserin
Ketanserin may increase the hypotensive activities of Fosinopril.
Ketoprofen
The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fosinopril.
Ketorolac
The risk or severity of adverse effects can be increased when Ketorolac is combined with Fosinopril.
Labetalol
Fosinopril may increase the hypotensive activities of Labetalol.
Lacidipine
Fosinopril may increase the hypotensive activities of Lacidipine.
Lanthanum Carbonate
The serum concentration of Fosinopril can be decreased when it is combined with Lanthanum carbonate.
Latanoprost
Fosinopril may increase the hypotensive activities of Latanoprost.
Leflunomide
The risk or severity of adverse effects can be increased when Leflunomide is combined with Fosinopril.
Lercanidipine
Fosinopril may increase the hypotensive activities of Lercanidipine.
Levobunolol
The risk or severity of adverse effects can be increased when Fosinopril is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Fosinopril.
Levodopa
Fosinopril may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Fosinopril.
Limonene, (+)-
The risk or severity of adverse effects can be increased when (4R)-limonene is combined with Fosinopril.
Linagliptin
The risk or severity of adverse effects can be increased when Linagliptin is combined with Fosinopril.
Lisinopril
Fosinopril may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Fosinopril may increase the hypotensive activities of Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Fosinopril.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Fosinopril.
Lofexidine
Fosinopril may increase the hypotensive activities of Lofexidine.
Lornoxicam
The risk or severity of adverse effects can be increased when Lornoxicam is combined with Fosinopril.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Fosinopril.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Fosinopril.
Loxoprofen
The risk or severity of adverse effects can be increased when Loxoprofen is combined with Fosinopril.
Macitentan
Fosinopril may increase the hypotensive activities of Macitentan.
Magaldrate
Magaldrate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Carbonate
Magnesium carbonate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fosinopril.
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Manidipine
Fosinopril may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Fosinopril is combined with Mannitol.
Masoprocol
The risk or severity of adverse effects can be increased when Masoprocol is combined with Fosinopril.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Fosinopril.
Meclofenamate
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fosinopril.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Fosinopril.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Fosinopril.
MELITRACEN
The serum concentration of Melitracen can be increased when it is combined with Fosinopril.
Meloxicam
The risk or severity of adverse effects can be increased when Meloxicam is combined with Fosinopril.
Meperidine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Pethidine.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Fosinopril.
Mepirodipine
Fosinopril may increase the antihypertensive activities of Barnidipine.
Mesalamine
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Mesalazine.
Mestranol
The serum concentration of Mestranol can be decreased when it is combined with Fosinopril.
Methazolamide
The risk or severity of adverse effects can be increased when Fosinopril is combined with Methazolamide.
Methohexital
Methohexital may increase the hypotensive activities of Fosinopril.
Methyclothiazide
The risk or severity of hypotension can be increased when Methyclothiazide is combined with Fosinopril.
Methyl Salicylate
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Methyl salicylate.
Methyldopa
Fosinopril may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Fosinopril may increase the hypotensive activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Fosinopril.
Methylergonovine
The serum concentration of Methylergometrine can be increased when it is combined with Fosinopril.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Fosinopril.
Metipranolol
Fosinopril may increase the hypotensive activities of Metipranolol.
Metolazone
The risk or severity of hypotension can be increased when Metolazone is combined with Fosinopril.
Metoprolol
Metoprolol may increase the hypotensive activities of Fosinopril.
Metyrosine
Fosinopril may increase the hypotensive activities of Metyrosine.
Mibefradil
Fosinopril may increase the hypotensive activities of Mibefradil.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Fosinopril.
Minaprine
Minaprine may increase the hypotensive activities of Fosinopril.
Minoxidil
Minoxidil may increase the hypotensive activities of Fosinopril.
Moclobemide
Moclobemide may increase the hypotensive activities of Fosinopril.
Moexipril
Fosinopril may increase the hypotensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Fosinopril.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Fosinopril.
Moxonidine
Moxonidine may increase the hypotensive activities of Fosinopril.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fosinopril.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Fosinopril.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Fosinopril.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Fosinopril.
Nabumetone
The risk or severity of adverse effects can be increased when Nabumetone is combined with Fosinopril.
Nadolol
Fosinopril may increase the hypotensive activities of Nadolol.
Naftifine
The risk or severity of adverse effects can be increased when Naftifine is combined with Fosinopril.
Naproxen
The risk or severity of adverse effects can be increased when Naproxen is combined with Fosinopril.
Nebivolol
Fosinopril may increase the hypotensive activities of Nebivolol.
Nefazodone
The serum concentration of Nefazodone can be increased when it is combined with Fosinopril.
Nepafenac
The risk or severity of adverse effects can be increased when Nepafenac is combined with Fosinopril.
Nesiritide
The risk or severity of adverse effects can be increased when Fosinopril is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Fosinopril.
Nicardipine
Fosinopril may increase the hypotensive activities of Nicardipine.
Nicorandil
Nicorandil may increase the vasodilatory activities of Fosinopril.
Nifedipine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Nifedipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Niflumic Acid is combined with Fosinopril.
Nilvadipine
Fosinopril may increase the hypotensive activities of Nilvadipine.
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Fosinopril.
Nimodipine
Nimodipine may increase the hypotensive activities of Fosinopril.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Fosinopril.
Nitrendipine
Fosinopril may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Fosinopril.
Nitroglycerin
The risk or severity of adverse effects can be increased when Fosinopril is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Fosinopril.
Nortriptyline
The serum concentration of Nortriptyline can be increased when it is combined with Fosinopril.
Obinutuzumab
Fosinopril may increase the hypotensive activities of Obinutuzumab.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Evening primrose oil is combined with Fosinopril.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Fosinopril.
Olopatadine
The risk or severity of adverse effects can be increased when Olopatadine is combined with Fosinopril.
Olsalazine
The risk or severity of adverse effects can be increased when Olsalazine is combined with Fosinopril.
Opipramol
The serum concentration of Opipramol can be increased when it is combined with Fosinopril.
Oxaprozin
The risk or severity of adverse effects can be increased when Oxaprozin is combined with Fosinopril.
Oxprenolol
Fosinopril may increase the hypotensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Fosinopril.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Fosinopril.
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Fosinopril.
Papaverine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Papaverine.
Parecoxib
The risk or severity of adverse effects can be increased when Parecoxib is combined with Fosinopril.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Fosinopril.
Pargyline
Pargyline may increase the hypotensive activities of Fosinopril.
Parthenolide
The risk or severity of adverse effects can be increased when Parthenolide is combined with Fosinopril.
Penbutolol
Fosinopril may increase the hypotensive activities of Penbutolol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Fosinopril.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Fosinopril.
Perindopril
Fosinopril may increase the hypotensive activities of Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Fosinopril.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Fosinopril.
Phenoxybenzamine
Fosinopril may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Fosinopril may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Fosinopril may increase the hypotensive activities of Phentolamine.
Phenylbutazone
The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Fosinopril.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fosinopril.
Pinacidil
Pinacidil may increase the hypotensive activities of Fosinopril.
Pindolol
Fosinopril may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Fosinopril.
Piretanide
Piretanide may increase the hypotensive activities of Fosinopril.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Fosinopril.
Piroxicam
The risk or severity of adverse effects can be increased when Piroxicam is combined with Fosinopril.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Piroxicam is combined with Fosinopril.
Polythiazide
The risk or severity of hypotension can be increased when Polythiazide is combined with Fosinopril.
Potassium
Potassium may increase the hyperkalemic activities of Fosinopril.
Potassium Bicarbonate
Potassium bicarbonate may increase the hyperkalemic activities of Fosinopril.
Potassium Chloride
Potassium Chloride may increase the hyperkalemic activities of Fosinopril.
Potassium Citrate
Potassium Citrate may increase the hyperkalemic activities of Fosinopril.
Potassium Ion
Potassium may increase the hyperkalemic activities of Fosinopril.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Fosinopril.
Prazosin
Prazosin may increase the hypotensive activities of Fosinopril.
Pregabalin
The risk or severity of angioedema can be increased when Fosinopril is combined with Pregabalin.
Primidone
Primidone may increase the hypotensive activities of Fosinopril.
Procaine
Procaine may increase the hypotensive activities of Fosinopril.
Procarbazine
Procarbazine may increase the hypotensive activities of Fosinopril.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Fosinopril.
Propranolol
Fosinopril may increase the hypotensive activities of Propranolol.
Protriptyline
The serum concentration of Protriptyline can be increased when it is combined with Fosinopril.
Quetiapine
The risk or severity of adverse effects can be increased when Fosinopril is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Fosinopril is combined with Quetiapine.
Quinapril
Fosinopril may increase the hypotensive activities of Quinapril.
Quinethazone
The risk or severity of hypotension can be increased when Quinethazone is combined with Fosinopril.
Quinine
Quinine may increase the hypotensive activities of Fosinopril.
Ramipril
Ramipril may increase the hypotensive activities of Fosinopril.
Rasagiline
Rasagiline may increase the hypotensive activities of Fosinopril.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Fosinopril.
Rescinnamine
Fosinopril may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Fosinopril.
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Fosinopril.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Fosinopril.
Riociguat
The serum concentration of Riociguat can be increased when it is combined with Fosinopril.
Risperidone
Fosinopril may increase the hypotensive activities of Risperidone.
Rituximab
Fosinopril may increase the hypotensive activities of Rituximab.
Rofecoxib
The risk or severity of adverse effects can be increased when Rofecoxib is combined with Fosinopril.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Fosinopril.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fosinopril.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Fosinopril.
Sacubitril
The risk or severity of angioedema can be increased when Fosinopril is combined with Sacubitril.
Salicylamide
The risk or severity of adverse effects can be increased when Salicylamide is combined with Fosinopril.
Salicylic Acid
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Salsalate is combined with Fosinopril.
Saralasin
The risk or severity of adverse effects can be increased when Saralasin is combined with Fosinopril.
Saxagliptin
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Fosinopril.
Saxagliptin Anhydrous
The risk or severity of adverse effects can be increased when Saxagliptin is combined with Fosinopril.
Secobarbital
Secobarbital may increase the hypotensive activities of Fosinopril.
Selegiline
Selegiline may increase the hypotensive activities of Fosinopril.
Selexipag
Fosinopril may increase the hypotensive activities of Selexipag.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Serrapeptase is combined with Fosinopril.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Fosinopril.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Fosinopril.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Fosinopril.
Sirolimus
The risk or severity of angioedema can be increased when Sirolimus is combined with Fosinopril.
Sitagliptin
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Fosinopril.
Sitagliptin Phosphate
The risk or severity of adverse effects can be increased when Sitagliptin is combined with Fosinopril.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate
Fosinopril may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Fosinopril may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Fosinopril may increase the nephrotoxic activities of Sodium phosphate.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Fosinopril.
Spirapril
Fosinopril may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.
ST. JOHN'S WORT EXTRACT
The metabolism of Fosinopril can be increased when combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Fosinopril.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Fosinopril.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Fosinopril.
Sulindac
The risk or severity of adverse effects can be increased when Sulindac is combined with Fosinopril.
Suprofen
The risk or severity of adverse effects can be increased when Suprofen is combined with Fosinopril.
Tacrolimus
The metabolism of Tacrolimus can be decreased when combined with Fosinopril.
Tadalafil
Tadalafil may increase the antihypertensive activities of Fosinopril.
Talinolol
Fosinopril may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Fosinopril.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Fosinopril.
Temsirolimus
The risk or severity of adverse effects can be increased when Fosinopril is combined with Temsirolimus.
Tenoxicam
The risk or severity of adverse effects can be increased when Tenoxicam is combined with Fosinopril.
Terazosin
The risk or severity of adverse effects can be increased when Fosinopril is combined with Terazosin.
Teriflunomide
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fosinopril.
Terlipressin
Fosinopril may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Fosinopril.
Theodrenaline
Fosinopril may increase the hypotensive activities of Theodrenaline.
Theophylline
The serum concentration of Theophylline can be decreased when it is combined with Fosinopril.
Theophylline anhydrous
The serum concentration of Theophylline can be decreased when it is combined with Fosinopril.
Thiamylal
Thiamylal may increase the hypotensive activities of Fosinopril.
Thiopental
Thiopental may increase the hypotensive activities of Fosinopril.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Fosinopril.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Fosinopril.
Tianeptine
The serum concentration of Tianeptine can be increased when it is combined with Fosinopril.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Fosinopril.
Tibolone
Fosinopril may increase the hypotensive activities of Tibolone.
Timolol
Timolol may increase the hypotensive activities of Fosinopril.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Fosinopril.
Tipranavir
The serum concentration of Fosinopril can be decreased when it is combined with Tipranavir.
Tizanidine
The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.
Tolazoline
Fosinopril may increase the hypotensive activities of Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Fosinopril.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Fosinopril.
Tolmetin
The risk or severity of adverse effects can be increased when Tolmetin is combined with Fosinopril.
Toloxatone
Toloxatone may increase the hypotensive activities of Fosinopril.
Tolvaptan
Tolvaptan may increase the hyperkalemic activities of Fosinopril.
Torsemide
Torasemide may increase the hypotensive activities of Fosinopril.
Trandolapril
Fosinopril may increase the hypotensive activities of Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Tranilast is combined with Fosinopril.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Fosinopril.
Travoprost
Travoprost may increase the hypotensive activities of Fosinopril.
Treprostinil
Treprostinil may increase the hypotensive activities of Fosinopril.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Fosinopril.
Triamterene
Triamterene may increase the hyperkalemic activities of Fosinopril.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Fosinopril.
Tribenoside
The risk or severity of adverse effects can be increased when Tribenoside is combined with Fosinopril.
Trichlormethiazide
The risk or severity of hypotension can be increased when Trichlormethiazide is combined with Fosinopril.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Fosinopril.
Trimethoprim
Trimethoprim may increase the hyperkalemic activities of Fosinopril.
Trimipramine
The serum concentration of Trimipramine can be increased when it is combined with Fosinopril.
Trolamine Salicylate
The therapeutic efficacy of Fosinopril can be decreased when used in combination with Trolamine salicylate.
Tromethamine
Tromethamine can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
UNOPROSTONE
Fosinopril may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Fosinopril.
Valdecoxib
The risk or severity of adverse effects can be increased when Valdecoxib is combined with Fosinopril.
Valproate
The serum concentration of Valproic Acid can be decreased when it is combined with Fosinopril.
Valproic Acid
The serum concentration of Valproic Acid can be decreased when it is combined with Fosinopril.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Fosinopril.
Vardenafil
Vardenafil may increase the antihypertensive activities of Fosinopril.
Verapamil
The metabolism of Verapamil can be decreased when combined with Fosinopril.
Vildagliptin
The risk or severity of adverse effects can be increased when Vildagliptin is combined with Fosinopril.
Vincamine
Fosinopril may increase the hypotensive activities of Vincamine.
Vinpocetine
Fosinopril may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Fosinopril may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Fosinopril.
Zidovudine
The serum concentration of Zidovudine can be decreased when it is combined with Fosinopril.
Zileuton
The risk or severity of adverse effects can be increased when Zileuton is combined with Fosinopril.
Zofenopril
Fosinopril may increase the hypotensive activities of Zofenopril.
Zomepirac
The risk or severity of adverse effects can be increased when Zomepirac is combined with Fosinopril.
